1. Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV
    Vittoria Graziani et al, 2019, Phytochemistry Reviews CrossRef
  2. New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the “Bacteria-Mucosal Immunity-Inflammation-Diabetes” Axis
    Zezheng Gao et al, 2017, Journal of Immunology Research CrossRef
  3. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis
    Mei-ting Song et al, 2018, Acta Pharmacologica Sinica CrossRef
  4. A review of saponin intervention in metabolic syndrome suggests further study on intestinal microbiota
    Zichen Luo et al, 2020, Pharmacological Research CrossRef
  5. Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation
    Chunyi Wang et al, 2018, Frontiers in Pharmacology CrossRef
  6. HPLC-MS and Network Pharmacology Analysis to Reveal Quality Markers of Huo-Xue-Jiang-Tang Yin, a Chinese Herbal Medicine for Type 2 Diabetes Mellitus
    Qiugu Chen et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  7. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects
    Jianqin Zhang et al, 2020, Pharmacological Advances in Natural Product Drug Discovery CrossRef
  8. Exercise-Induced Browning of White Adipose Tissue and Improving Skeletal Muscle Insulin Sensitivity in Obese/Non-obese Growing Mice: Do Not Neglect Exosomal miR-27a
    Dongxue Wang et al, 2022, Frontiers in Nutrition CrossRef
  9. Variations in the insulin receptor substrate 1 (IRS1) and its association with growth traits in Chinese black Tibetan sheep (Ovis aries)
    Li Zhou et al, 2021, Animal Biotechnology CrossRef
  10. Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo study
    Xin Tao et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  11. Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats
    Dong Han, 2021, Journal of International Medical Research CrossRef
  12. Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety
    Qiangqiang Jia et al, 2019, Phytomedicine CrossRef
  13. Hotspot Analysis of Traditional Drugs in Diabetes Treatment Literature
    Hui Shen et al, 2021, Chinese Journal of Integrative Medicine CrossRef
  14. Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
    Jun Li et al, 2019, Frontiers in Pharmacology CrossRef
  15. Identification and characterization of proteins that are differentially expressed in adipose tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative proteomics
    Ni Yang et al, 2020, Journal of Proteomics CrossRef
  16. The regulatory role of dietary factors in skeletal muscle development, regeneration and function
    Liyi Wang et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  17. Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase
    Wei Wang et al, 2019, Journal of Ovarian Research CrossRef
  18. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells
    Xiao Zhou et al, 2021, Journal of Ethnopharmacology CrossRef